Changing Lifestyle Choices of Women and Late Pregnancies Driving Demand for Oral Contraceptive Pills

Contraceptive or birth control pill is a daily pill that contains hormones to change the way the body works and prevent pregnancy. Two main types of oral contraceptive pills are available in the market: combination pill containing two hormones (estrogen and progestin) and progestin-only pill. High incidence of unintended pregnancies and awareness programs organized by governments and NGOs drive the global demand for oral contraceptive pills. Moreover, increasing maternal age and late pregnancies coupled with family planning by most couples have triggered the growth of the market.

Based on the types of products, the global oral contraceptive pills market has been categorized into combination pills, progestin only pills and others. Combination pills are type of oral contraceptive pills that contain progestin and ethinyl estradiol that are similar to natural sex hormones estrogen and progesterone produced in a woman’s body. Combination pills are further segmented into monophasic, triphasic, and other (biphasic and quadriphasic) based on the level of hormones present among females during the first three weeks of the menstrual cycle. The monophasic combination pills sub-segment accounted for nearly majority of the market share of the combination pills segment in 2014 due to higher effectiveness and growing preference for monophasic pills. Monophasic pills are available in three different doses of estrogen: low dose (20 mcg), regular dose (30 mcg to 35 mcg), and high dose (50 mcg). Low estrogen monophasic pills cause less bloating or breast tenderness. Hence, most women consider monophasic pill as a first line of choice for contraception.

Based on category, the global oral contraceptive pills market has been segmented into branded and generic oral contraceptive pills. Globally, the market is dominated by generic contraceptive pills due to availability of cost effective (low cost) drugs with similar bioavailability and bioequivalence as the branded drugs, rising preference for generic drugs among patients, and growing awareness about unintended pregnancies. This situation is more intense in the developing nations in Asia Pacific. The market in the region is expected to expand at the highest CAGR during the forecast period.

Download Free exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8323

Geographically, the global contraceptive pills market has been differentiated into the following regions: North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America dominated the global contraceptive pills market in 2014 due to the high incidence rate of unintended pregnancies, availability of favorable reimbursement policies after implementation of the Affordable Care Act and increased use of emergency contraceptive pills and oral contraceptive pills. On the other hand, Asia Pacific is estimated as the most opportunistic market during the forecast period due to strong economic growth in countries such as India, China, Singapore, Philippines, Australia, and others. This in turn, has led to increased awareness about the use of contraception for pregnancy prevention, rising disposable income and demand for healthy life, which is increasing the adoption rate of contraceptive pills in Asia Pacific.

The global contraceptive pills market is characterized by the presence of major companies such as Actavis, Inc., Bayer AG, Church & Dwight, Co., Inc., Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Mankind Pharma, and Piramal Enterprises Ltd. These market players are engaged in growth strategies such as acquisitions, marketing of products (providing free samples or contraceptives in reduced prices) and introducing various awareness programs to increase the market share and sustain in the highly competitive contraceptive pills market.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.